APOA1 Antikörper

Produktnummer ABIN116540

Produktdetails anti-APOA1 Antikörper

Target: APOA1 (Apolipoprotein A-I (APOA1))

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser APOA1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Spezifität: Typically less than 1 % cross reactivity against other types of Apolipoprotein was detected by ELISA against purified standards. This antibody reacts with Human Apolipoprotein A-I and has negligible cross-reactivity with Type A-II, B, C-I, C-II, C-III, E and J Apolipoproteins. Non-specific cross reaction of anti-Apolipoprotein antibodies with other Human serum proteins is negligible.

Kreuzreaktivität (Details): Species reactivity (tested):Human.

Aufreinigung: Immunoaffinity Chromatography using immobilized antigens followed by extensive cross-adsorption against other Apolipoproteins and human serum proteins to remove any unwanted specificities.

Immunogen: Apolipoprotein Type A-I was isolated from Human plasma by density gradient centrifugation followed by HPLC purification.

Anwendungsinformationen

Applikationshinweise: Anti-Apolipoprotein antibodies have been used for Indirect trapping ELISA for quantitationof antigen in serum using a standard curve, for Immunoprecipitation and for Westernblotting for highly sensitive qualitative analysis. Recommended dilutions: ELISA: 1/10,000-1/20,000. Western blot: 1/5,000-1/10,000. Immunoprecipitation: 1/100. Immunohistochemistry: 1/50-1/200.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL (by UV absorbance at 280 nm)

Buffer: 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0, 0.01 % Sodium Azide, None

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Dilute only prior to immediate use. Avoid cycles of freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store vial at -20 °C prior to opening. Centrifuge product if not completely clear after standing at room temperature. For extended storage aliquot contents and freeze at -20 °C or below.

Referenzen für anti-APOA1 Antikörper (ABIN116540)

Bernthaler, Epping, Schmitz, Deplazes, Brehm: "Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode." in: Infection and immunity, Vol. 77, Issue 12, pp. 5564-71, (2009) (PubMed).

Details zu APOA1

Target: APOA1 (Apolipoprotein A-I (APOA1))

Andere Bezeichnung: Apolipoprotein A I (APO AI) (APOA1 Produkte)

Synonyme: Alp-1 antikoerper, Apoa-1 antikoerper, Brp-14 antikoerper, Ltw-1 antikoerper, Lvtw-1 antikoerper, Sep-1 antikoerper, Sep-2 antikoerper, Sep2 antikoerper, apoA-I antikoerper, apoa antikoerper, apoa1 antikoerper, cb49 antikoerper, wu:fb33f01 antikoerper, zgc:103718 antikoerper, MGC64335 antikoerper, MGC89745 antikoerper, Apo-AI antikoerper, ApoA-I antikoerper, APOA1 antikoerper, LOC100136573 antikoerper, apoa-i antikoerper, ApoAI antikoerper, apolipoprotein A1 antikoerper, apolipoprotein A-I antikoerper, apolipoprotein A-Ia antikoerper, apolipoprotein A-I S homeolog antikoerper, apolipoprotein A4 antikoerper, APOA1 antikoerper, Apoa1 antikoerper, apoa1a antikoerper, apoa1.S antikoerper, apoa1 antikoerper, LOC100136573 antikoerper, apoa-i antikoerper, apoa4 antikoerper

Hintergrund: Apolipoprotein A I promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A I is the major protein component of high density lipoprotein (HDL) in the plasma. Synthesized in the liver and small intestine, it consists of two identical chains of 77 amino acids, an 18 amino acid signal peptide is removed co-translationally and a 6 amino acid propeptide is cleaved post-translationally. Apolipoprotein A I is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.Synonyms: APOA1, Apo-AI, ApoA-I, ApoAI

Gen-ID: 335

NCBI Accession: NP_000030

UniProt: P02647

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism